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We examined white matter abnormalities in patients with a distinctive extrapyramidal syndrome due to intravenous methcathi-
none (ephedrone) abuse. We performed diffusion tensor imaging in 10 patients and 15 age-matched controls to assess white
matter structure across the whole brain. Diffuse significant decreases in white matter fractional anisotropy, a diffusion tensor
imaging metric reflecting microstructural integrity, occurred in patients compared with controls. In addition, we identified two
foci of severe white matter abnormality underlying the right ventral premotor cortex and the medial frontal cortex, two cortical
regions involved in higher-level executive control of motor function. Paths connecting different cortical regions with the globus
pallidus, the nucleus previously shown to be abnormal on structural imaging in these patients, were generated using probabil-
istic tractography. The fractional anisotropy within all these tracts was lower in the patient group than in controls. Finally, we
tested for a relationship between white matter integrity and clinical outcome. We identified a region within the left corticospinal
tract in which lower fractional anisotropy was associated with greater functional deficit, but this region did not show reduced
fractional anisotropy in the overall patient group compared to controls. These patients have widespread white matter damage
with greatest severity of damage underlying executive motor areas.
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Introduction
A distinctive extrapyramidal syndrome occurs in intravenous
methcathinone abusers (Levin, 2005; de Bie et al., 2007;
Sanotsky et al., 2007; Sikk et al., 2007; Selikhova et al., 2008;
Stepens et al., 2008; Colosimo and Guidi, 2009; Varlibas et al.,
2009). Methcathinone is an euphoric stimulant, known as ephe-
drone in the former USSR, which is manufactured by potassium
permanganate oxidation, in the presence of acetic acid, of the
ephedrine and pseudoephedrine contained in readily available
pharmaceuticals (Zingel et al., 1991; Emmerson and Cisek,
1993). Methcathinone is not isolated in a purified form and intra-
venous injection exposes users to a high manganese load
(Sikk et al., 2007).
Affected users develop a neurological disorder attributed to tox-
icity from the residual manganese in the injected methcathinone
solution. Clinically this involves varying combinations of hypokine-
sia, dysarthria, dystonia and postural instability (Stepens et al.,
2008). A typical patient shows facial impassivity, generally
slowed movement, low volume speech, micrographia and a lurch-
ing gait on the balls of the feet with absent arm swing. Walking
backwards is particularly difficult. Mild executive dysfunction has
been detected in some (Selikhova et al., 2008). Unlike Parkinson’s
disease, there is no rest tremor, lead pipe rigidity, shuffling gait or
gait initiation failure. Most patients are unable to work and daily
activities are severely restricted, mainly due to gait difficulties and
postural instability.
The syndrome is remarkably stereotyped and in active users is
associated with a distinctive T1-weighted MRI signal hyperintensity
in the globus pallidus and substantia nigra attributable to manga-
nese deposition; blood manganese levels are markedly elevated
(Sikk et al., 2007; Selikhova et al., 2008; Stepens et al., 2008).
Although this signal hyperintensity resolves with cessation of
methcathinone usage, the clinical syndrome does not improve
and is not significantly responsive to antiparkinsonian therapies
(Selikhova et al., 2008; Stepens et al., 2008). Furthermore, dopa-
mine transporter single photon emission CT is normal (Selikhova
et al., 2008; Sikk et al., 2009) but PET shows widespread,
non-uniform, decreased fludeoxyglucose uptake (Sikk et al.,
2009). Neuropathological studies of manganese neurotoxicity
following occupational or experimental exposure demonstrate
cell loss and gliosis in the globus pallidus, particularly the pars
interna, with sparing of the substantia nigra pars compacta;
Lewy bodies are absent (Olanow et al., 1996; Perl and Olanow,
2007). Manganese-induced neurodegeneration occurs in the
frontal cortex of non-human primates associated with a functional
deficit in fine motor control (Guilarte et al., 2006, 2008).
Given the distinctive nature of the motor abnormalities in
these patients, we investigated whether the syndrome is asso-
ciated with particular damage to tracts involved in motor control.
Although T1-weighted scans are normal in these patients, apart
from the basal ganglia, conventional structural MRI is not always
sensitive to diffuse neuronal loss. Diffusion tensor imaging (DTI)
is a non-invasive MRI technique sensitive to the self-diffusion
of water molecules and provides measures of white matter
microstructure. Two DTI metrics, fractional anisotropy and mean
diffusivity, are sensitive to subtle white matter abnormalities in
various neurological conditions. Decreases in fractional anisotropy
reflect a decrease in structure within a tract; factors influencing
fractional anisotropy include membrane and myelin integrity and
fibre density, but the biological basis of the measure is complex
(Beaulieu, 2009). Mean diffusivity is elevated with tissue degen-
eration and oedema (Assaf, 2008). In Parkinson’s disease,
decreased fractional anisotropy has been observed in white
matter tracts within the frontal lobes (Yoshikawa et al., 2004;
Karagulle Kendi et al., 2008; Gattellaro et al., 2009). Changes in
mean diffusivity in Parkinson’s disease are less consistent across
studies; some studies have reported a decrease in mean diffusivity
in these areas (Gattellaro et al., 2009), whereas other studies have
found mean diffusivity to be normal (Schocke et al., 2002, 2004;
Nicoletti et al., 2006; Karagulle Kendi et al., 2008).
We used DTI to investigate forebrain white matter integrity in
methcathinone abusers and particularly examined connections
between the globus pallidus and cortex.
Materials and methods
Patients
Ten intravenous drug addicts [mean age 40 years (range 30–55),
2 female] who had used methcathinone for an average period of
8 years (range 1–23) and showed the typical extrapyramidal disorder,
and 15 controls [mean age 38 years (range 25–56), 2 female] were
studied at the University Hospital ‘Gailezers’, Riga, Latvia in 2008–09.
None had a family history of neurological disease, a history of
Parkinson’s disease or clinical evidence of Lewy body disease.
Informed consent was obtained in accordance with the Declaration
of Helsinki and ethical approval was granted by the University
Hospital, Riga.
Posture, speech and writing were graded as normal, mild, moderate
or severe. All patients were rated on the unified Parkinson’s disease
rating scale, UPDRS (Fahn et al., 1987), a broad measure of parkin-
sonian symptoms (range 0–176, higher scores indicate more severe
disability). As these patients had a pure motor disorder, we utilized
the scores from the motor subsection of the UPDRS (section III) for
our correlation measures (motor subscore range 0–108; higher scores
indicate more severe disability) (Fahn et al., 1987), although it is
important to note that this subscore was highly correlated with the
total score for these patients, as would be expected in patients with a
pure motor disorder.
MRI
Diffusion-weighted magnetic resonance images were acquired on a
1.5 T GE Systems magnetic resonance scanner at the University
Hospital ‘Gailezers’, Riga, Latvia with a maximum gradient strength of
40 mT/m. Echo-planar images of the whole head were acquired (time to
repetition = 8500 ms, echo time = 93.9 ms, 275-mm-thick axial
slices, in-plane resolution 1.01.0 mm). The diffusion weighting was
isotropically distributed in 25 directions using a b-value of 1000 s/mm2.
One volume with no diffusion weighting was also acquired.
In order for high-resolution tractography to be performed to define
pathways of interest between the globus pallidus and cortex, nine
healthy controls [mean 27 years (range 22–33), 1 male] were recruited
with approval from the Central Oxford Research Ethics Committee and
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gave their informed consent in accordance with the Declaration of
Helsinki. Diffusion-weighted magnetic resonance images were
acquired on a Siemens Sonata 1.5 T scanner at the Oxford Centre
for Magnetic Resonance, Oxford, UK, with a maximum gradient
strength of 40 mT/m. Three sets of echo-planar images of the whole
head were acquired, each with nine volumes with no diffusion weight-
ing (722-mm-thick axial slices, giving an isotropic resolution of
22 2 mm). Diffusion weighting was isotropically distributed along
60 directions using a b-value of 1000 s/mm2. This high-resolution
dataset was used to define tracts of interest, which were then used
to derive quantitative values from age-matched controls and patients;
no statistical analysis was performed comparing the controls from the
high-resolution dataset with the patient group.
Data analysis
All diffusion data were transformed using affine registration to correct
for eddy currents and head motion (Jenkinson et al., 2002) and
non-brain tissue was removed (Smith, 2002). The Centre for
Functional Magnetic Resonance Imaging of the Brain’s diffusion
toolbox, part of the Centre for Functional Magnetic Resonance
Imaging of the Brain software library (FSL, http://www.fmrib.ox.ac
.uk/fsl) (Smith et al., 2004), was used to fit a diffusion tensor model
to the data at each voxel. Voxel-wise values of fractional anisotropy
and mean diffusivity were then calculated.
Whole brain analysis
Tract-based spatial statistics (TBSS, also part of FSL), a method for
voxel-wise statistical comparison of diffusion indices between individ-
uals, was used to test for differences in fractional anisotropy and mean
diffusivity between patients and controls across the whole brain white
matter (Smith et al., 2006) (see Supplementary material).
To test for group differences in fractional anisotropy or mean diffu-
sivity between patients and controls, we used the randomize program
within FSL to carry out permutation-based testing. Statistical thresh-
olding was carried out in two complementary ways: (i) by cluster-
based analysis [with corrected cluster (P50.05) using threshold-free
cluster enhancement (TFCE) as implemented within randomize], which
is sensitive to spatially extensive areas of significant difference; and (ii)
by a voxel-based thresholding approach, which is most sensitive to
highly significant differences with small spatial extent. For this
voxel-based approach, significant regions were defined by first thresh-
olding the raw t-statistic map on the skeleton at t(23) 43.76, giving
an (uncorrected) P50.001. Significant regions were then defined by a
cluster extent of 425 mm3 (equivalent to 5 voxels in native space).
This threshold is equivalent to a map-wise false-positive rate of
50.0005 (estimated using a Monte Carlo procedure as implemented
in the AlphaSim program in the analysis of functional neuroimages
software package).
For ease of visualization, the results of both the cluster-based and
voxel-based analyses were thickened using tbss_fill (within FSL). This
thickens the tracts by smoothing with a 3 mm Gaussian kernel, whilst
maintaining the maximum statistic values and limiting the extent of
the spread to voxels in the white matter (defined as fractional anisot-
ropy 40.2).
We performed a separate within-group analysis of the patient group
to test for areas within the white matter skeleton where disability
scores correlated with fractional anisotropy or mean diffusivity.
Clusters were defined using equivalent thresholding approaches
{TFCE (with cluster P50.05, corrected) and voxel-based thresholding
[with t(9) 44.29, giving an (uncorrected) P50.001, cluster extent
of 425 mm3]}.
Clusters showing significant effects on between-group and
within-group analyses with TBSS were used as seed masks for
multi-fibre probabilistic tractography (Behrens et al., 2003, 2007)
(see Supplementary material) to determine the pathways passing
through white matter regions of significant fractional anisotropy or
mean diffusivity change. Due to the relatively low resolution of the
data collected from the patients and age-matched controls, tractogra-
phy was performed on higher resolution, isotropic, diffusion weighted
images acquired from a separate cohort of healthy controls. It is im-
portant to note, however, that these data were not used for any
statistical analysis, but only to more accurately define white matter
tracts implicated.
Pathways of interest analysis
We had a priori hypotheses about involvement of pathways from the
globus pallidus in this patient group, given the abnormalities observed
in this structure on T1-weighted MRI. Thus we performed tractography
in each high-resolution diffusion dataset to delineate the connections
between the globus pallidus and cortical masks, via the thalamus (see
Supplementary material), to test specifically for fractional anisotropy or
mean diffusivity changes within pathways from the globus pallidus to
the cortex. The cortical areas selected were those known to have
strong connections with the globus pallidus: primary motor cortex,
supplementary motor area (SMA), frontal eye fields, anterior cingulate
gyrus, lateral orbital cortex, dorsolateral prefrontal cortex and
pre-SMA. Repeated measures ANOVAs were performed to assess
the significance of any differences between the groups.
Region of interest analysis of globus pallidus
We wished to investigate differences in mean diffusivity within the
globus pallidus itself between patients and controls. To do this, we
investigated the average mean diffusivity within the globus pallidus
using an anatomical mask (see Supplementary material) for each sub-
ject. A two-sample t-test was performed to assess the significance of
any difference between the groups.
Results
Clinical features
The clinical features of all 10 patients are summarized in Table 1.
MRI
Group differences
A significant increase of 7% in average mean diffusivity within
the globus pallidus bilaterally was observed within the patient
population compared with the mean value in controls [patients
mean diffusivity 8.04 0.09 (104) (mean SE); controls mean
diffusivity 7.49 0.05 (104); P50.001].
To investigate global differences between patients and controls
in white matter integrity, we tested for differences across the
whole white matter skeleton. Overall, patients had a 5% reduction
in mean fractional anisotropy compared to controls [patients
fractional anisotropy 0.39 0.003 (mean SE); controls fractional
anisotropy 0.37 0.007; t(23) = 2.74; P = 0.01]. Next, we
performed a cluster-based (TFCE) analysis within TBSS with a
cluster P = 0.05 (corrected). TCFE results are fully corrected for
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family-wise error across the white matter skeleton. Extensive and
diffuse areas of decreased fractional anisotropy in patients were
observed within the white matter skeleton, particularly in more
anterior tracts (Fig. 1A). Within this region, patients had a 15%
reduction in mean fractional anisotropy compared to controls
(controls 0.48 0.01; patients 0.41 0.01).
We additionally tested for foci of extreme differences in white
matter fractional anisotropy between patients and controls using
voxel-based thresholding in TBSS. Using this approach, we found
two regions of white matter in which the fractional anisotropy was
significantly lower in patients than in controls (Table 2, Fig. 1B and
C). Both these regions were within the areas of decreased frac-
tional anisotropy in patients demonstrated using TFCE. These clus-
ters were used as seeds for probabilistic tractography, which
allowed us to identify these regions as belonging to the anterior
corpus callosum connecting the pre-SMA, and to white matter
underlying the right ventral premotor cortex (Table 2, Fig. 1B
and C). Fractional anisotropy was reduced in these areas by
21% within the region in the anterior corpus callosum and 22%
within the region underlying the right ventral premotor cortex.
Both these regions were within the areas of decreased fractional
anisotropy in patients demonstrated using TFCE.
In the whole brain analysis areas of increased mean diffusivity in
the patient group co-distributed with areas of decreased fractional
anisotropy (data not shown), but these mean diffusivity increases
did not reach statistical significance with either TFCE or
voxel-based thresholding.
In addition to whole-brain analysis, we investigated fractional
anisotropy and mean diffusivity within known connections
between the globus pallidus and distinct cortical areas. There
was no main effect of hemisphere [F(1,24) = 2.59; P = 0.12], there-
fore mean fractional anisotropy values for the tracts from the two
hemispheres were averaged for analyses and a repeated measures
ANOVA was performed to test for differences in mean fractional
anisotropy within the globus pallidus-cortical tracts between
patients and controls. The repeated measures ANOVA revealed
a significant main effect of cortical area (primary motor cortex,
SMA, frontal eye fields, anterior cingulate gyrus, lateral orbital
cortex, dorsolateral prefrontal cortex, pre-SMA) [main effect of
area: F(6,138) = 1051, P50.001] and a significant overall differ-
ence in mean fractional anisotropy between patient and control
groups [main effect of group: F(1,23) = 6.61, P = 0.01], as well as
a significant interaction between area and group [interaction of
area group: F(6,138) = 6.00, P50.001]. Post hoc t-tests demon-
strated a reduction in fractional anisotropy in patients compared to
controls within each of these tracts (Table 3).
A repeated measures ANOVA was performed to test for differ-
ences in average mean diffusivity within the globus pallidus-
cortical tracts between controls. There was a significant main
effect of cortical area (primary motor cortex, SMA, frontal eye
fields, anterior cingulate gyrus, lateral orbital cortex, dorsolateral
prefrontal cortex, pre-SMA) [F(6,138) = 529, P50.002], a
significant overall difference in average mean diffusivity between
the patient and control groups [F(1,23) = 5742, P50.001] and a
significant interaction between area and group [F(6,138) = 3.39,
P = 0.004]. Post hoc t-tests demonstrated a trend towards an
increase in mean diffusivity in the patient group in each of these
tracts, though this did not reach significance.
Correlations with disability
Clinical scores were correlated with white matter fractional anisot-
ropy within the patient population. No significant clusters were
identified using TFCE, but using voxel-based correction there
was a significant correlation between the UPDRS motor subscore
and fractional anisotropy in one region (Table 2, Fig. 2A), such
that patients with a higher motor subscore (i.e. those with greater
disability) had lower fractional anisotropy in this region (Fig. 2C).
Probabilistic tractography allowed us to identify this region as be-
longing to the left corticospinal tract (Fig. 2B). Motor subscore and
total UPDRS score were highly correlated within this patient group
(r = 0.97, P50.001) and the same region showed a significant
correlation between total UPDRS score and fractional anisotropy.
This region did not appear to have reduced fractional anisotropy in
the patient group as a whole in our analysis of between-group
differences (Fig. 1A). Consistent with this, a region of interest
analysis on this cluster showed that the fractional anisotropy
within this region was not significantly lower in patients than in
controls (Fig. 2D).
Table 1 Patient characteristics
Clinical severity UPDRS
Patient Sex Age HIV
status
Gait Speech Writing Rigidity Tremor Akinesia MMSE Total Motor Methcathinone
usage
1 F 42 Negative Moderate Mild Mild None None Moderate 26 36 20 Active
2 M 36 Positive Severe Severe Moderate None None Moderate 30 42 22 Active
3 M 44 AIDS Severe Severe Moderate None None Severe 29 60 35 Former
4 M 40 AIDS Severe Moderate Moderate None None Moderate 29 45 28 Active
5 M 37 AIDS Moderate Severe Severe None None Moderate 29 32 17 Former
6 M 34 Negative Moderate Moderate Moderate None None Moderate 30 48 25 Former
7 M 38 Negative Severe Severe Severe None None Severe 28 55 31 Former
8 M 46 Positive Moderate Moderate Moderate None None Moderate 27 33 19 Active
9 M 55 Negative Mild Moderate Mild None None Moderate 27 42 23 Former
10 F 30 AIDS Moderate Moderate Mild None None Moderate 27 38 22 Active
MMSE = Mini-mental state examination; UPDRS = unified Parkinson’s disease rating scale.
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Figure 1 Group differences in fractional anisotropy between patients and controls. (A) Blue regions indicate areas showing a significant
reduction in fractional anisotropy in patients compared to controls in a cluster-based analysis (significant clusters have been thickened for
ease of visualization) (TFCE; corrected P50.05). Widespread abnormalities are observed in white matter tracts within the central regions
of the brain, more peripheral tracts are relatively unaffected. (B and C) Areas showing decreased fractional anisotropy in patients
compared to controls using voxel-based thresholding. The first column shows regions of significant reduction in fractional anisotropy in
yellow (significant clusters have been thickened for ease of visualization) [t43.76; P50.001 (uncorrected); cluster extent425 mm3]. The
mean fractional anisotropy skeleton is shown in green and the areas of significant difference illustrated in A are shown in blue. The middle
column shows the paths (derived using high-resolution diffusion data from healthy volunteers) originating from the clusters of significant
difference shown in the first column where the colour coding reflects the proportion of the population in which a tract is present. Tracts
have been thresholded to show only those present in 3 subjects. The third column shows the mean fractional anisotropy in patients and
controls within the significant clusters. FA = fractional anisotropy; L = lateral; P = posterior.
Table 2 White matter regions in which fractional anisotropy values (A) were significantly lower in patients than controls,







(A) Patients versus controls
Under right ventral premotor cortex 6.35 31 43 2 33
Right corpus callosum 4.63 34 11 13 25
(B) Correlation with UPDRS (motor subscore)
Left corticospinal tract 5.79 47 25 25 37
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A similar region was identified in the right corticospinal tract,
but the cluster extent (15 mm3) did not reach our significance
threshold (425 mm3). Analysis of mean diffusivity demonstrated
no areas of significant correlation with UPDRS scores.
We found no correlations between clinical score and either
fractional anisotropy or mean diffusivity within the globus
pallidus-cortical tracts.
Discussion
We identified white matter abnormalities in methcathinone
abusers with an extrapyramidal syndrome. Evidence for diffuse
white matter change was reflected by reductions in fractional
anisotropy within the central white matter of the patient group.
In addition, we found focally severe reductions in fractional
anisotropy in the patient group—specifically in areas underlying
the right ventral premotor cortex and the medial prefrontal
cortex. A correlation between clinical severity and white matter
integrity was demonstrated within the left corticospinal tract, in
a region that appears to be relatively spared in the group as a
whole.
Given the nature of the underlying toxicity in these patients,
widespread damage to the white matter tracts, as evidenced by
reduction in fractional anisotropy, might have been expected.
Figure 2 Correlations with clinical score. (A) The blue region indicates an area showing a significant correlation between UPDRS motor
subscore and fractional anisotropy using voxel-based thresholding [t44.78, P50.001 (uncorrected), cluster extent425 mm3]. (B) The
results of probabilistic tractography using this region as a seed mask in high-resolution data, demonstrating it lies within the left corticospinal
tract, where the colour coding reflects the proportion of the population in which a tract is present. Tracts have been thresholded to show only
those present in at least three out of nine subjects. (C) Correlation between UPDRS motor subscore and fractional anisotropy (FA) within this
region. (D) Range of FA within this region in patients and controls (points represent individual subjects).
Table 3 Summary of mean fractional anisotropy within
globus pallidus–cortical tracts used for the pathways of
interest analysis
Region Mean fractional anisotropy P-value
Controls Patients
Primary motor cortex 0.290.002 0.28 0.006 0.02
SMA 0.310.002 0.29 0.006 0.02
Frontal eye fields 0.310.002 0.30 0.006 0.02
Anterior cingulate gyrus 0.300.003 0.27 0.007 0.01
Lateral orbital cortex 0.270.002 0.26 0.005 0.02
Dorsolateral prefrontal cortex 0.290.002 0.27 0.006 0.02
Pre-SMA 0.310.002 0.29 0.006 0.02
The mean fractional anisotropy within these pathways was reduced in the patient
group compared to the controls (mean SE). Post hoc t-tests were performed
to assess the significance of this difference. The resulting P-value is shown in
Column 4. SMA = supplementary motor area.
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More noteworthy is the demonstration of focal regions of substan-
tial reduction in fractional anisotropy. The clinical features of these
patients point to a disorder of higher-level motor programming.
They have notable difficulty with backwards motion, tend to fall if
walking backwards, sit by falling backwards and recover poorly on
backwards displacement. An early symptom is difficulty in getting
out of cars and one patient had extreme difficulty propelling his
wheelchair backwards using his hands, despite easily moving it
forwards (Stepens et al., 2008). This pattern of motor deficits re-
sembles executive dysfunction displayed by patients with prefront-
al lesions who typically have difficulties in inhibiting a prepotent
response (Mostofsky and Simmonds, 2008). The regions of the
medial and inferior lateral frontal cortex implicated here are
involved in circumstances where an initial response must be sup-
pressed to perform a different required action (Aron et al., 2004;
Nachev et al., 2007; Mostofsky and Simmonds, 2008; Mars et al.,
2009; Buch et al., 2010) and individual differences in the micro-
structure of white matter pathways that interconnect with the
pre-SMA and ventral premotor cortex correlate with physiological
measures of response inhibition, even in healthy subjects (Mars
et al., 2009; Buch et al., 2010). The difficulty these patients
have in moving backwards may therefore result from an inability
to suppress the primary action of walking forwards.
T1-weighted structural MRI reveals the globus pallidus as the
primary site of manganese deposition in these patients (Stepens
et al., 2008). We have demonstrated increased mean diffusivity
in this area, unlike Parkinson’s disease (Chan et al., 2007), sug-
gesting loss of microstructural integrity specifically in our patient
group. The anatomical connectivity of the globus pallidus involves
basal ganglia cortical loops with areas of prefrontal, premotor and
motor cortex (Middleton and Strick, 2000) and DTI confirms
similar connections in humans (Draganski et al., 2008). We used
tractography to test specifically for white matter abnormalities
within globus pallidus–cortical connections and demonstrated
widespread damage across all tracts. Although the ANOVA
revealed an interaction suggesting the globus pallidus–cortical
connections are differentially affected by the disease process,
our post hoc t-tests detected a decreased fractional anisotropy
in patients in all tracts. There are a number of reasons that
an increase in mean diffusivity and a decrease in fractional anisot-
ropy might be observed in the globus pallidus–cortical pathways. It
might be that manganese toxicity leads to a more widespread
pattern of neuronal damage than that inferred from conventional
MRI. Alternatively, it might be that there is a decrease in fractional
anisotropy in these tracts as a secondary trans-synaptic conse-
quence of damage to the globus pallidus, and therefore a decrease
in tract integrity is observed secondary to a decrease in the
pre-synaptic globus pallidus–thalamic connections.
By contrast to the globus pallidus–cortical connections, the
corticospinal tracts appear to be relatively spared, in keeping
with the lack of pyramidal signs in these patients. In combination
with the result of the whole brain analysis, this anatomical
pattern reinforces the clinical notion of a higher-level motor
programming disorder. However, despite the relative sparing of
the corticospinal tracts, we also demonstrated a significant correl-
ation between fractional anisotropy within the left corticospinal
tract and clinical score in the patients. This may suggest
that pre-existing variation in this pathway influences motor func-
tion in patients, reminiscent of correlations between fractional
anisotropy and performance described in healthy volunteers
(Johansen-Berg et al., 2007).
Tractography has not been used previously to investigate man-
ganese toxicity. DTI has been used to investigate Parkinson’s dis-
ease and parkinsonian syndromes, showing decreased fractional
anisotropy outside the basal ganglia within the genu of the
corpus callosum and the superior longitudinal fasciculus, and
within fontal lobe areas, premotor areas and the cingulum
(Yoshikawa et al., 2004; Karagulle Kendi et al., 2008; Gattellaro
et al., 2009). Although two of these previous studies in
non-demented patients report decreased fractional anisotropy in
widespread regions of frontal white matter that include locations
demonstrated here (Karagulle Kendi et al., 2008; Gattellaro et al.,
2009), it is important to reiterate that the extrapyramidal syn-
drome in methcathinone abusers differs markedly from that of
Parkinson’s disease.
The focal white matter abnormality underlying the ventral pre-
motor cortex was only detected in the right hemisphere, even
after relaxing the statistical thresholding (P50.05 uncorrected,
voxel extent 425 mm3; data not shown). There is a known func-
tional laterality within the motor system in that the left premotor
cortex is dominant for selection of motor actions (Cavina-Pratesi
et al., 2006). It is not clear why the right ventral premotor cortex
is more sensitive in this context, given that the pathology, con-
ventional magnetic resonance changes and clinical disorder are
symmetric. However, it is interesting to note that a previous
study on Parkinson’s disease reported right lateralized changes in
white matter fractional anisotropy in a location encompassing this
region (Karagulle Kendi et al., 2008).
There is a complex neurobiological basis for the fractional
anisotropy measure used here. Fractional anisotropy is modulated
by factors such as myelination, membrane integrity or axonal
packing density (Beaulieu, 2009). In the context of toxin-induced
neuronal loss, the decreases are likely to reflect decreased axonal
packing density; however this cannot be proven definitively using
this technique. Additionally, possible compensatory adaptive
changes in myelination, for example, cannot be excluded
(Tanaka et al., 2003). More complex acquisition and analysis of
diffusion data may allow modelling of specific microstructural
features such as axon diameter (Assaf et al., 2008).
Of our six HIV-positive patients, four had AIDS. We confirmed
that HIV status has no effect on differences between patients and
controls (data not shown). Although these conditions can lead to
white matter abnormalities, a recent study demonstrated no dif-
ference in fractional anisotropy between HIV-positive patients and
healthy controls (Gongvatana et al., 2009). Although decreases in
fractional anisotropy have been observed in patients with AIDS
they mainly relate to dementia (Mirsattari et al., 1998).
Methodological limitations
Our studied patient population is relatively small, a common limi-
tation of imaging studies in rare disorders. Despite the small group
sizes, we detected consistent changes to guide future studies on
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larger groups. In the current study we were unable to test quan-
titatively for grey matter changes due to the limited resolution of
T1-weighted images. Future studies should investigate disease-
related changes in the grey matter areas that interconnect with
the white matter regions indentified here. The resolution of the
DTI data for patients and age-matched controls was also relatively
low and this may have reduced our sensitivity to focal effects
and limited the accuracy of cross-subject alignment. Registration
accuracy was checked for all subjects and we de-projected signifi-
cant clusters back into native DTI space for each individual to
confirm that skeleton voxels were indeed projected from the
white matter in all cases.
Conclusion
We have demonstrated widespread white matter abnormalities in
patients with a manganese-induced extrapyramidal syndrome.
Particular abnormalities were noted within white matter underlying
two regions known to be involved in higher-level motor processes,
which may explain the stereotypic motor impairment of these pa-
tients. The detection of these abnormalities outside areas known
to be connected directly to the globus pallidus suggests a more
widespread neuronal pathology than previously demonstrated by
conventional imaging techniques, thereby extending our under-
standing of the anatomical basis of this disorder.
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